Blood triglycerides metabolism

The term "blood triglycerides metabolism" refers to the *biochemical pathways and physiological processes* involved in the breakdown, synthesis, transport, and storage of triglycerides (also known as triacylglycerols) in the bloodstream. Triglycerides are the major component of dietary and endogenous fat, consisting of a glycerol backbone esterified to three fatty acids. They are transported in the blood primarily by lipoproteins such as chylomicrons and very-low-density lipoproteins (VLDL)[1][2][5]. The metabolism of blood triglycerides is a complex, multi-step process involving numerous enzymes (such as lipoprotein lipase), cofactors (apolipoproteins including Apo CII, Apo CIII, Apo AV), and tissues (intestine, liver, adipose, muscle)[2][4][5]. Triglycerides themselves are *not individual molecular targets*, receptors, or enzymes but rather substrates within metabolic pathways. These pathways are targeted indirectly by drugs or therapeutic strategies aimed at specific enzymes (e.g., lipoprotein lipase), co-factors, or proteins involved in lipoprotein metabolism[2]. Thus, "blood triglycerides metabolism" does not represent a canonical biomolecular target such as a receptor, enzyme, transporter, or gene; instead, it reflects an entire metabolic process[1][2][5]. A correct therapeutic target name should be specific, such as "lipoprotein lipase," "apolipoprotein C-III," or "diacylglycerol O-acyltransferase" (DGAT)[2][4][7]. If you are interested in drug targeting, you should consider whether you mean one of these enzymes, cofactors, or receptors involved in the metabolism of blood triglycerides. **Summary of conventions:** - The entry does not refer to a specific, actionable molecule or receptor. - "Blood triglycerides metabolism" is not a canonical or singular target but a process. - Proper targets within this process would include enzymes such as lipoprotein lipase or proteins like apolipoprotein C-III[2][4][7]. - Additional information and structured data require a more specific biomolecular target. **Conclusion:** "Blood triglycerides metabolism" is a metabolic process, not a specific therapeutic target (receptor, enzyme, transporter, etc.). To obtain structured information relevant to drug targeting, a specific molecule or protein within this pathway must be specified.

Other names

Triglyceride metabolismTriacylglycerol metabolismTG metabolism